Usana Health Sciences (USNA) Inventory (2011 - 2026)

Usana Health Sciences (USNA) has reported Inventory for 16 consecutive years, with $86.3 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Inventory rose 3.69% year-over-year to $86.3 million in Q3 2026; TTM through Jul 2026 was $86.3 million, a 3.69% increase from a year earlier, with the FY2026 full-year figure at $102.6 million, up 47.14% from the prior year.
• Inventory was $86.3 million for Q3 2026 at Usana Health Sciences, down from $96.4 million in the prior quarter.
• Over five years, Inventory peaked at $102.6 million in Q1 2026 and troughed at $60.1 million in Q3 2023.
• A 5-year average of $76.4 million and a median of $69.7 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory plunged 33.91% in 2023 and surged 47.14% in 2026, its largest moves.
• Over 5 years, Inventory stood at $67.1 million in 2022, then fell by 8.4% to $61.5 million in 2023, then increased by 13.48% to $69.7 million in 2024, then jumped by 30.18% to $90.8 million in 2025, then dropped by 4.89% to $86.3 million in 2026.
• The last three Inventory figures came in at $86.3 million (Q3 2026), $96.4 million (Q2 2026), and $102.6 million (Q1 2026), per Business Quant data.